ArticleFrontiers in nutrition2026
Association between the prognostic nutritional index and impulse control disorders in patients with early-stage Parkinson's disease.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Impulse control disorders (ICDs) are common non-motor symptoms in Parkinson's disease (PD) and associated with significant psychiatric morbidity and reduced quality of life. The prognostic nutritional index (PNI) reflects both nutritional and immune status. However, the relationship between PNI and ICDs in early-stage PD remains unknown. Methods: This cross-sectional study included 1,302 early-stage PD patients (Hoehn and Yahr stages 1-3) from the Parkinson's Progression Markers Initiative (PPMI) database. Logistic regression models were constructed with sequential adjustment for demographic, clinical, neuropsychiatric, metabolic, and laboratory covariates. Sensitivity analyses included complete-case analysis, exclusion of participants with abnormal liver or renal function, and propensity score-based methods (IPTW, SMRW, PA). Receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were calculated to assess incremental predictive value. Results: The overall prevalence of ICDs was 22.6% (294/1,302). In the fully adjusted model, each 1-unit increase in PNI was associated with 5% lower odds of ICDs (OR = 0.95, 95% CI: 0.92-0.98, Conclusions: Higher PNI is independently associated with lower odds of ICDs in early-stage PD patients. PNI, a simple and readily available composite marker of nutritional and immune status, may serve as a valuable adjunctive tool for discriminating PD patients with higher odds of prevalent ICDs. Prospective longitudinal studies are warranted to establish causality and explore potential nutritional or immunomodulatory interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.